Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Latest Advances in
Allergic Bronchopulmonary Aspergillosis
Overview
Find a Doctor
Latest Advances
Clinical Trials
Latest Advances
Condition:
Allergic Bronchopulmonary Aspergillosis
Journal:
International archives of allergy and immunology
Treatment Used:
Omalizumab
Number of Patients:
25
Published —
May 11, 2020
In this study, researchers evaluated the safety and effectiveness of using omalizumab for the treatment of allergic bronchopulmonary aspergillosis in patients with chronic bacterial infections in the airways.
Condition:
Mycobacterium Avium Complex Lung Disease
Journal:
Respiratory medicine
Treatment Used:
Aspergillus Precipitating Antibody Test
Number of Patients:
131
Published —
April 24, 2020
This study tested the safety and efficacy of using an aspergillus precipitating antibody test to diagnose patients with mycobacterium avium complex lung disease.
Condition:
Behçet's Disease with Invasive Pulmonary Aspergillosis and Aspergillus Auriculatus Infection
Journal:
Medicine
Treatment Used:
Anti-Fungals and Corticosteroids
Number of Patients:
1
Published —
February 07, 2020
This case report discusses a 26-year-old woman diagnosed with Behçet's disease, an inflammatory disease that leads to multisystemic immune dysfunction and that involves pulmonary system alterations, with invasive pulmonary aspergillosis and Aspergillus auriculatus infection treated with anti-fungals and corticosteroids.
Condition:
Pulmonary Thromboembolism (PTE) Following Allergic Bronchopulmonary Aspergillosis (ABPA)
Journal:
Medicine
Treatment Used:
Antifungal Drugs and Corticosteroids
Number of Patients:
1
Published —
January 09, 2020
This case report describes a 64-year-old man diagnosed with pulmonary thromboembolism (clot; PTE) following allergic bronchopulmonary aspergillosis (ABPA) treated with antifungal drugs and corticosteroids.
Condition:
Allergic Bronchopulmonary Aspergillosis
Journal:
British journal of clinical pharmacology
Treatment Used:
Inhalated Formulation of Itraconazole (PUR1900)
Number of Patients:
0
Published —
November 08, 2019
This study evaluated an inhaled formulation of itraconazole (PUR1900) in patients with allergic bronchopulmonary aspergillosis (an allergic inflammatory disease occurring in asthmatics and patients with cystic fibrosis).
Condition:
Invasive Pulmonary Aspergillosis (IPA) in Critically Ill Patients with Hematological Malignancies (HM)
Journal:
Intensive care medicine
Treatment Used:
Voriconazole
Number of Patients:
219
Published —
October 11, 2019
This study assessed whether advances in medical management improved survival in critically ill patients with with hematological malignancies (HM) with acute respiratory failure and invasive pulmonary aspergillosis (fungal lung infection; IPA).
Condition:
Pulmonary Aspergillosis
Journal:
Mycoses
Treatment Used:
Nebulised Amphoterricin B Deoxycholate (Fungizone)
Number of Patients:
177
Published —
September 04, 2019
This study evaluated the safety and effectiveness of nebulised amphoterricin B deoxycholate (Fungizone) in patients with pulmonary Aspergillosis.
Condition:
Invasive Pulmonary Aspergillosis
Journal:
Deutsche medizinische Wochenschrift (1946)
Treatment Used:
Voriconazole or Triazole Isavuconazole
Number of Patients:
0
Published —
August 28, 2019
This article discusses invasive pulmonary aspergillosis and its diagnosis and treatment.
Condition:
Asthma and Allergic Bronchopulmonary Aspergillosis
Journal:
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Treatment Used:
Omalizumab
Number of Patients:
27
Published —
August 14, 2019
This study assessed the safety and effectiveness of omalizumab for the treatment of asthma and allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
Condition:
Invasive Aspergillosis
Journal:
Mycoses
Treatment Used:
Combination Antifungal Therapy
Number of Patients:
454
Published —
July 30, 2019
This study tested the safety and efficacy of using combination antifungal therapy to treat patients with invasive aspergillosis.
Condition:
Children with cystic fibrosis and Aspergillus-related lung disease
Journal:
Medical mycology
Treatment Used:
Posaconazole therapy
Number of Patients:
14
Published —
March 17, 2019
The study researched the effect of Posaconazole therapy (anti-fungal) in children with cystic fibrosis and Aspergillus-related lung disease.
Condition:
Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
Journal:
The Journal of antimicrobial chemotherapy
Treatment Used:
Posaconazole
Number of Patients:
32
Published —
February 27, 2019
The study researched the effects of Posaconazole for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
Showing 1-12 of 18
Next